WeVote

Bill

Bill

LB 253

Provide for insurance and medicaid coverage of biomarker testing

109th Legislature (2025-2026) Introduced by Bob Andersen and 3 co-sponsors

Bill 2 SummaryBill Number: LB 253Title: Provide for insurance and medicaid coverage of biomarker testingSummary:- Requires health insurers and Medicaid to cover biomarker testing w

Title printed. Carryover bill
0
WeVote Research Nonpartisan
Bill Summary · LB 253

Bill 2 Summary

Bill Number: LB 253
Title: Provide for insurance and medicaid coverage of biomarker testing

Summary:
- Requires health insurers and Medicaid to cover biomarker testing when supported by medical and scientific evidence
- Covers biomarker testing for diagnosis, treatment, management, or monitoring of a disease or condition
- Provides a list of tests supported by evidence that must be covered
- Requires insurers to limit disruptions in care, such as the need for multiple biopsies
- Mandates a 72-hour (24-hour for urgent) approval/denial process for prior authorization requests
- Gives patients and providers a clear process to request exceptions to coverage policies or adverse prior authorization decisions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.